A Medical Breakthrough the Market Overlooked | David Elsley – Cardiol Therapeutics

FULL DISCLOSURE: Cardiol Therapeutics is a sponsor of theDeepDive.ca.

In this interview David Elsley, CEO of Cardiol Therapeutics (NASDAQ: CRDL) (TSXV: CRDL), shares some compelling clinical data that could be a real game-changer for treating dangerous heart swelling. The research focuses on addressing early warning signs that are connected to serious cardiac conditions, which could make a meaningful difference for patient outcomes.

The conversation dives into how their approach might offer safer treatment paths for patients struggling with recurring heart inflammation, which can be incredibly painful and debilitating. David gives a clear picture of where this research stands and what it could mean for people facing these serious cardiac challenges.


FULL DISCLOSURE: Cardiol Therapeutics is a client of Canacom Group, the parent company of The Deep Dive. Canacom Group is currently long the equity of Cardiol Therapeutics. The author has been compensated to cover Cardiol Therapeutics on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. We may buy or sell securities in the company at any time. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Epic Gold Outlines 150,700 Indicated Ounces at 2.26 G/T in Updated Benoist Resource

Related News

Gareth Soloway: Tesla, Ford, Bitcoin, and Yield Curves for 2022 – The Daily Dive

In our first Daily Dive for the year, we welcome back Gareth Soloway of InTheMoneyStocks.com....

Friday, January 7, 2022, 01:30:00 PM

Grid 2.0 – How Home Energy Storage Will Change The Grid – The Daily Dive feat Justin Holland

Today on the Daily Dive is that of Justin Holland, CEO of Eguana Technologies (TSXV:...

Thursday, January 21, 2021, 01:30:00 PM

Plurilock’s Behavioral Biometrics: Next-Gen Cybersecurity with Scott Meyers

In this interview, Scott Meyers, CFO of Plurilock Security Inc. (TSXV: PLUR, OTCQB: PLCKF), provides...

Thursday, September 12, 2024, 01:42:00 PM

The Future of Cannabis Delivery – The Daily Dive feat Adam Berk of Driven By Stem

Today on the Daily Dive, host Cassandra Leah is joined by Adam Berk, CEO of...

Wednesday, January 20, 2021, 01:30:00 PM

Buy Silver When Gold Ratio Hits 90 – It Works Every Time? | John Feneck

In this interview, seasoned investor John Feneck, CEO of Feneck Consulting, provides a comprehensive overview...

Saturday, March 22, 2025, 11:19:00 AM